Due to the insufficient sensitivity of other markers in the differential diagnosis of anemia in IBD, high expectations were associated with the determination of hepcidin, as well as new laboratory parameters including erythroferrone and BMP-6 levels. The gene discussed is HAMP; the disease is inflammatory bowel disease.